Drugs / GET73
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT04831684 | Sep 2021 → Dec 2025 | alcohol-related disorders | Medical University of South Carolina | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT03418623 | Mar 2018 → Mar 2020 | alcohol-related disorders | Laboratorio Farmaceutico Ct S.r.l. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT01842503 Comparator | Nov 2014 → Nov 2018 | alcohol dependence | Laboratorio Farmaceutico Ct S.r.l. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GET73 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03418623 ↗ |
| Modality | Small molecule | — CHEMBL4297543 ↗ |
| Route | Oral | “GET73 300 mg oral capsules” NCT03418623 ↗ |